These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18381416)

  • 1. Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers.
    Yamashita S; Takahashi S; McDonell N; Watanabe N; Niwa T; Hosoya K; Tsujino Y; Shirai T; Ushijima T
    Cancer Res; 2008 Apr; 68(7):2112-21. PubMed ID: 18381416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer.
    Zhao H; Shiina H; Greene KL; Li LC; Tanaka Y; Kishi H; Igawa M; Kane CJ; Carroll P; Dahiya R
    Cancer; 2005 Jul; 104(1):44-52. PubMed ID: 15895377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
    Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
    Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic inactivation of Betaig-h3 gene in human cancer cells.
    Shao G; Berenguer J; Borczuk AC; Powell CA; Hei TK; Zhao Y
    Cancer Res; 2006 May; 66(9):4566-73. PubMed ID: 16651406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reciprocal role of prostate cancer on stromal DNA damage.
    Banerjee J; Mishra R; Li X; Jackson RS; Sharma A; Bhowmick NA
    Oncogene; 2014 Oct; 33(41):4924-31. PubMed ID: 24141771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insensitivity to transforming growth factor-beta results from promoter methylation of cognate receptors in human prostate cancer cells (LNCaP).
    Zhang Q; Rubenstein JN; Jang TL; Pins M; Javonovic B; Yang X; Kim SJ; Park I; Lee C
    Mol Endocrinol; 2005 Sep; 19(9):2390-9. PubMed ID: 15905358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
    Osada H; Tatematsu Y; Sugito N; Horio Y; Takahashi T
    Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells.
    Singal R; van Wert J; Bashambu M
    Cancer Res; 2001 Jun; 61(12):4820-6. PubMed ID: 11406558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic inactivation of the dioxin-responsive cytochrome P4501A1 gene in human prostate cancer.
    Okino ST; Pookot D; Li LC; Zhao H; Urakami S; Shiina H; Igawa M; Dahiya R
    Cancer Res; 2006 Aug; 66(15):7420-8. PubMed ID: 16885337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation mediated silencing of TMS1/ASC gene in prostate cancer.
    Das PM; Ramachandran K; Vanwert J; Ferdinand L; Gopisetty G; Reis IM; Singal R
    Mol Cancer; 2006 Jul; 5():28. PubMed ID: 16848908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional epigenomics identifies genes frequently silenced in prostate cancer.
    Lodygin D; Epanchintsev A; Menssen A; Diebold J; Hermeking H
    Cancer Res; 2005 May; 65(10):4218-27. PubMed ID: 15899813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation-associated silencing of the heat shock protein 47 gene in human neuroblastoma.
    Yang Q; Liu S; Tian Y; Hasan C; Kersey D; Salwen HR; Chlenski A; Perlman EJ; Cohn SL
    Cancer Res; 2004 Jul; 64(13):4531-8. PubMed ID: 15231663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma.
    Fukai K; Yokosuka O; Chiba T; Hirasawa Y; Tada M; Imazeki F; Kataoka H; Saisho H
    Cancer Res; 2003 Dec; 63(24):8674-9. PubMed ID: 14695180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation silencing of angiopoietin-like 4 in rat and human mammary carcinomas.
    Hattori N; Okochi-Takada E; Kikuyama M; Wakabayashi M; Yamashita S; Ushijima T
    Cancer Sci; 2011 Jul; 102(7):1337-43. PubMed ID: 21489049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer.
    Wang LG; Beklemisheva A; Liu XM; Ferrari AC; Feng J; Chiao JW
    Mol Carcinog; 2007 Jan; 46(1):24-31. PubMed ID: 16921492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation in the androgen receptor gene promoter region in rat prostate cancers.
    Takahashi S; Inaguma S; Sakakibara M; Cho YM; Suzuki S; Ikeda Y; Cui L; Shirai T
    Prostate; 2002 Jun; 52(1):82-8. PubMed ID: 11992622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulated expression of urokinase and its inhibitor type 1 in prostate cancer cells: role of epigenetic mechanisms.
    Hagelgans A; Menschikowski M; Fuessel S; Nacke B; Arneth BM; Wirth MP; Siegert G
    Exp Mol Pathol; 2013 Jun; 94(3):458-65. PubMed ID: 23541763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
    Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
    Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.